Among the 30 genes with the greatest bias in their expression change according to Oncodrive-CIS were CCNE1 and PTEN due to amplifications and CDKN2A, NF1, and NCOA4 due to deletions (Figures S4, S5 and S6). This evidence concerns the gene NF1 and in situ carcinoma.